期刊文献+

奥硝唑栓治疗滴虫性阴道炎的双盲随机对照多中心临床试验 被引量:15

Randomized,double-blind,controlled,multicenter clinical trial of ornidazole suppositories in the treatment of trichomonal vaginitis
在线阅读 下载PDF
导出
摘要 目的评价奥硝唑栓(第3代硝基咪唑类抗滴虫药)治疗滴虫性阴道炎的临床疗效和安全性。方法用随机、双盲、平行对照、多中心临床试验,试验组113例,对照组112例,分别给予奥硝唑栓或甲硝唑栓,每日1枚(500mg)置入阴道,共5天。于停药3~5天、月经净后3~7天随访,观察症状、体征并进行阴道分泌物病原学检查。结果停药3-5天随访,2组的症状、体征和病原学指标均有明显改善,试验组、对照组的有效率(滴虫阴性率)分别为95.58%、97.32%,差异无统计学意义。月经后随访,试验组、对照组的有效率分别为89.38%、79.46%,2组比较有非常显著性差异(P<0.001)。试验组、对照组的药物不良反应发生率分别为9.57%、9.48%,差异无统计学意义。结论奥硝唑栓治疗滴虫性阴道炎安全、有效。 Objective To evaluate the efficacy and safey of ornidazole suppositories in the treatment of trichomonal vaginitis. Methods Double -blind randomized controlled muhicenter clinical trial was conducted. The trial group of 113 cases were given ornidazole suppositories and the control group of 112 cases were given metronidazole suppositories. The suppositories were inserted into vagina once a day for five days, respectively. The clinical symptoms, signs as well as pathogens were observed 3 ~5 days after end of treatment and 3 ~ 7days after menorrhea. Results After treatment , the effifiency(eradicated rates of pathogen) of the trial group was 95.58% and which of the control group was 97.32% ,respectively. There were no significant statistic difference between two groups. Three to 7days after menorrhea, the effifiency( eradicated rates of pathogen) of the trial group was 89.38% and which of the control group was 79.46% ,respectively(P 〈 0.001 ). The total rate of adverse reaction of trial and control groups were 9.58%, 9.48% respectively. There were no significant statistic difference between two groups. Conclusion It is suggested that ornidazole suppositories was safe and efficient in the treatment of trichomonal vaginitis.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2008年第3期195-198,共4页 The Chinese Journal of Clinical Pharmacology
关键词 奥硝唑栓 甲硝唑栓 滴虫性阴道炎 ornidazole suppositories metronidazole suppositories trichomonal vaginitis
  • 相关文献

参考文献7

  • 1Swygard H, Sena AC, Hobbs MM,et al. Trichomoniasis: Clinical manifestations, diagnosis and management [ J ]. Sex Transm Infect, 2004 ;80 : 91 -95.
  • 2Lo M, Reid M,Brokenshire M. Resistance of trichomonas vaginalis infections to metronidzole in Auckland sexual health clinics : report of two cases[ J]. J New Zealand Med Assioclat,2002 ; 155 : 1160 - 1162.
  • 3Tobin AM, Wilson JD. Management of metronidazole resistent trichomomas vaginalis - a new approach [ J ]. Int J Std Aids, 2005 ;16:488 - 490.
  • 4Fugeve P, Verschelded G, Caron M. Single oral dose of ornidazole in women with vaginal trichomoniasis [ J ] . Obstet Gyenecol, 1983 ;62:502 - 505.
  • 5Lamp KC, Freeman CD, Klutman NE. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials [ J ]. Clin Phzarmacokinet, 1999 ;36:353 - 357.
  • 6汤慧芳,龚培力,周际安,李英茜,郑启昌,戴立人,闵洁,李兴睿,彭志翔,陈茹,丁俊清,罗新,王培良,蒲子敬,杨恒.奥硝唑片治疗急性厌氧菌感染性疾病及阴道毛滴虫病的临床试验[J].中国新药杂志,2001,10(11):833-836. 被引量:49
  • 7李爱斌 罗新 徐顺先 等.奥硝唑治疗滴虫性阴道炎的临床观察.白求恩医科大学学报,2001,27:84-86.

二级参考文献3

共引文献49

同被引文献113

引证文献15

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部